{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:54:34Z","timestamp":1781646874445,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100028779","name":"Consortium for Medical Marijuana Clinical Outcomes Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100028779","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cannabis Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Exercise and sports-related musculoskeletal injuries often result in pain, and the recovery process can be prolonged and challenging. Many physically-active Americans have begun using cannabidiol (CBD) for pain relief and improved recovery time, and CBD is of particular interest due to its positive safety profile, non-intoxicating effects, and therapeutic potential. Our objectives were threefold. First, to confirm the safety and tolerability of ingesting a CBD-rich hemp-extract. Second, we examined the feasibility and acceptability of our recruitment and blinding methods, and the tests and measures used to determine preliminary efficacy. Last, we planned to examine within-group effect sizes and observed power to make preliminary determinations of efficacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A randomized, placebo-controlled, double-blind, two-arm parallel study design was used with participants randomly allocated to either a CBD or a placebo control group. Participants completed a 15-day study trial which included baseline testing, intervention (CBD\/placebo dosing), and follow-up assessments on days 11 through day 15 (24 to 96-hrs post-injury). Outcomes included pain intensity, strength loss, and physical disability. Participants self-administered the investigational product (CBD or placebo) under the tongue twice daily for 15 days. Daily dosage of CBD was 67\u00a0mg. An experimental injury protocol for the quadriceps muscle group on day 10 induced pain and functional disability in otherwise healthy men (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20099) and women (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200920) [age: 20.1 yrs, weight: 64.2\u2009\u00b1\u20098.5\u00a0kg, height: 169\u2009\u00b1\u20095.3\u00a0cm].\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were no reports from participants of side effects or treatment-emergent adverse reactions from consuming the investigational products. Symptoms and functional deficits were most pronounced 24 to 48\u00a0h. post-injury and were least pronounced by 96-hrs post-injury. CBD users reported less peak pain at rest and with movement at 48-hrs post-injury. The CBD group showed less strength impairment and physical disability than placebo at 48-hrs post-injury.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Sublingually administered CBD demonstrated a favorable safety profile and showed promise in reducing pain-related symptoms associated with exercise-induced muscle injury. Clinical studies using larger sample sizes are needed to confirm the reported estimates of efficacy in reducing pain and improving function post-injury.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>NCT04586712, registered on October 14, 2020.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42238-026-00431-x","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T06:04:30Z","timestamp":1774937070000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of cannabidiol (CBD) on reducing pain and functional impairment associated with exercise-induced muscle injury: a randomized placebo-controlled feasibility trial"],"prefix":"10.1186","volume":"8","author":[{"given":"JW","family":"Stauffer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JA","family":"Crow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MD","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RL","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PA","family":"Borsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"issue":"11","key":"431_CR1","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.jpain.2007.06.004","volume":"8","author":"MP Abrams","year":"2007","unstructured":"Abrams MP, Carlton RN, Asmundson GJG. An exploration of the psychometric properties of the PASS-20 with a nonclinical sample. J Pain. 2007;8(11):879\u201386.","journal-title":"J Pain"},{"issue":"11","key":"431_CR2","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1177\/03635465221109573","volume":"50","author":"MJ Alaia","year":"2022","unstructured":"Alaia MJ, Hurley ET, Vasavada K, Markus DH, Britton B, Gonzalez-Lomas G, Rokito AS, Jazrawi LM, Kaplan K. Buccally absorbed cannabidiol shows significantly superior pain control and improved satisfaction immediately after arthroscopic rotator cuff repair: A placebo-controlled, double-blinded, randomized trial. Am J Sports Med. 2022;50(11):3056\u201363.","journal-title":"Am J Sports Med"},{"issue":"4","key":"431_CR3","first-page":"371","volume":"79","author":"JM Binkley","year":"1999","unstructured":"Binkley JM, Stratford PW, Lott SA, Riddle DL. The Lower Extremity Functional Scale (LEFS): scale development, measurement properties, and clinical application. North American Orthopaedic Rehabilitation Research Network. Phys Ther. 1999;79(4):371\u201383.","journal-title":"Phys Ther"},{"key":"431_CR4","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","volume":"134","author":"T Bisogno","year":"2001","unstructured":"Bisogno T, Hanus L, DePetrocellis L, et al. Molecular targets for cannabidiol and its synthetic analogues: effect of vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br J Pharmacol. 2001;134:845\u201352.","journal-title":"Br J Pharmacol"},{"issue":"13","key":"431_CR5","doi-asserted-by":"publisher","first-page":"929487","DOI":"10.3389\/fpsyg.2022.929487","volume":"22","author":"TJ Brooks","year":"2022","unstructured":"Brooks TJ, Bradstreet TC, Partridge JA. Current concepts and practical applications for recovery, growth, and peak performance following significant athletic injury. Front Psychol. 2022;22(13):929487. https:\/\/doi.org\/10.3389\/fpsyg.2022.929487. eCollection 2022.","journal-title":"Front Psychol"},{"issue":"1607","key":"431_CR6","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1098\/rstb.2011.0389","volume":"367","author":"AC Campos","year":"2012","unstructured":"Campos AC, Moreira FA, Gomes FV, Del Bel EA, Guimar\u00e3es FS. Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. Philos Trans R Soc Lond B Biol Sci. 2012;367(1607):3364\u201378.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"431_CR7","unstructured":"Cannabidiol. May market size, trends, dynamics and consumer preferences & behavior. https:\/\/www.towardshealthcare.com\/insights\/cannabidiol-market-sizing. Assessed 22 2025."},{"key":"431_CR8","unstructured":"Cheng B. Cannabinoids market to triple to 60 billion by 2030, CBD segment leads U.S. sales. Global Cannabis Times. https:\/\/globalcannabistimes.com\/cannabinoids-market-to-triple-to-60-billion-by-2030-cbd-segment-leads-u-s-sales\/.\u00a0Published 5 Sep 2022. Accessed 21 Mar 2023."},{"issue":"7","key":"431_CR9","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1249\/MSS.0000000000002606","volume":"53","author":"KC Cochrane-Snyman","year":"2021","unstructured":"Cochrane-Snyman KC, Cruz C, Morales J, Coles M. The effects of cannabidiol oil on noninvasive measures of muscle damage in men. Med Sci Sports Exerc. 2021;53(7):1460\u201372.","journal-title":"Med Sci Sports Exerc"},{"issue":"S2","key":"431_CR10","first-page":"6","volume":"25","author":"J Corroon","year":"2019","unstructured":"Corroon J, Felice JF. The endocannabinoid system and its modulation by cannabidiol (CBD). Altern Ther Health Med. 2019;25(S2):6\u201314.","journal-title":"Altern Ther Health Med"},{"issue":"1","key":"431_CR11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1089\/can.2018.0006","volume":"3","author":"J Corroon","year":"2018","unstructured":"Corroon J, Phillips JA. A cross-sectional study of cannabidiol users. Cannabis Cannabinoid Res. 2018;3(1):152\u201361.","journal-title":"Cannabis Cannabinoid Res"},{"key":"431_CR12","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","volume":"163","author":"L DePetrocellis","year":"2011","unstructured":"DePetrocellis L, Ligresti A, Moriello AS, et al. Effects of cannabinoids and cannabinoid-enriched cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br J Pharmacol. 2011;163:1479\u201394.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"431_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/1941738120901670","volume":"12","author":"S Docter","year":"2020","unstructured":"Docter S, Khan M, Gohal C, Ravi B, Bhandari M, Gandhi R, et al. Cannabis use and sport: A systematic review. Sports Health. 2020;12(2):189\u201399.","journal-title":"Sports Health"},{"issue":"14","key":"431_CR14","doi-asserted-by":"publisher","first-page":"8711","DOI":"10.1074\/jbc.M114.618447","volume":"290","author":"MW Elmes","year":"2015","unstructured":"Elmes MW, Kaczocha M, Berger WT, Leung K, Ralph BP, Wang L, Sweeney JM, Miyauchi JT, Tsirka SE, Ojima I, Deutsch DG. Fatty acid-binding proteins (FABPs) are intracellular carriers for \u22069-tetrahydrocannabinol (THC) and cannabidiol (CBD). J Biol Chem. 2015;290(14):8711\u201321.","journal-title":"J Biol Chem"},{"key":"431_CR15","doi-asserted-by":"crossref","unstructured":"El Sohly MA, Radwan MM, Gul W, Chandra S, Galal A. Phytochemistry of cannabis sativa L., In: Kinghorn A, Falk H, Gibbons S, Kobayashi, J, editors. Prog Chem Org Nat Prod. 2017;103:1\u201336.","DOI":"10.1007\/978-3-319-45541-9_1"},{"key":"431_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s42238-022-00154-9","volume":"4","author":"N Frane","year":"2022","unstructured":"Frane N, Stapleton E, Iturriaga C, et al. Cannabidiol as a treatment for arthritis and joint pain: an exploratory cross-sectional study. J Cannabis Res. 2022;4:47. https:\/\/doi.org\/10.1186\/s42238-022-00154-9.","journal-title":"J Cannabis Res"},{"issue":"1","key":"431_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.pain.0000000000000012","volume":"156","author":"SZ George","year":"2015","unstructured":"George SZ, Wallace MR, Wu SS, Moser MW, Wright TW, Farmer KW, Borsa PA, Parr JJ, Greenfield WH, Dai Y, Li H, Fillingim RB. Biopsychosocial influence on shoulder pain: risk subgroups translated across preclinical and clinical prospective cohorts. Pain. 2015;156(1):148\u201356.","journal-title":"Pain"},{"key":"431_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cct.2017.03.005","volume":"56","author":"SZ George","year":"2017","unstructured":"George SZ, Staud R, Borsa PA, Wu SS, Wallace MR, Greenfield WG, Mackie LN, Fillingim RB. Biopsychosocial influence on shoulder pain: Rationale and protocol for a pre-clinical trial. Contemp Clin Trials. 2017;56:9\u201317.","journal-title":"Contemp Clin Trials"},{"issue":"2","key":"431_CR19","first-page":"89","volume":"7","author":"A Hackett","year":"2020","unstructured":"Hackett A, Armstrong K, Hughes B, Parr B. The influence cannabidiol on delayed onset of muscle soreness. Int J Phys Ed Sport Health. 2020;7(2):89\u201394.","journal-title":"Int J Phys Ed Sport Health"},{"issue":"2","key":"431_CR20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap) - - a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42(2):377\u201381.","journal-title":"J Biomed Inf"},{"issue":"3","key":"431_CR21","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41401-018-0031-9","volume":"40","author":"AS Laun","year":"2018","unstructured":"Laun AS, Shrader SH, Brown KJ, Song ZH. GPR3, GPR6, and GPR12 as novel molecular targets: their biological functions and interaction with cannabidiol. Acta Pharmacol Sin. 2018;40(3):300\u20138.","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"431_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.csm.2011.09.009","volume":"31","author":"PB Lewis","year":"2012","unstructured":"Lewis PB, Ruby D, Bush-Joseph CA. Muscle soreness and delayed-onset muscle soreness. Clin J Sport Med. 2012;31(2):255\u201362.","journal-title":"Clin J Sport Med"},{"issue":"4","key":"431_CR23","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/aje\/kwt013","volume":"178","author":"L Li","year":"2013","unstructured":"Li L, Setoguchi S, Cabral H, Jick S. Opioid Use for Noncancer Pain and Risk of Fracture in Adults: A Nested Case-Control Study Using the General Practice Research Database. Am J Epidemiol. 2013;178(4):559\u201369.","journal-title":"Am J Epidemiol"},{"key":"431_CR24","doi-asserted-by":"publisher","first-page":"112600","DOI":"10.1016\/j.fct.2021.112600","volume":"157","author":"J Li","year":"2021","unstructured":"Li J, Carvajal R, Bruner L, Kaminski NE. The current understanding of the benefits, safety, and regulation of cannabidiol in consumer products. Food Chem Toxicol. 2021;157:112600.","journal-title":"Food Chem Toxicol"},{"issue":"1","key":"431_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2165\/00007256-199520010-00003","volume":"20","author":"DL MacIntyre","year":"1995","unstructured":"MacIntyre DL, Reid WD, McKenzie DC. Delayed muscle soreness. Sports Med. 1995;20(1):24\u201340.","journal-title":"Sports Med"},{"key":"431_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4103\/sni.sni_45_18","volume":"9","author":"J Maroon","year":"2018","unstructured":"Maroon J, Bost J. Review of the neurological benefits of phytocannabinoids. Surg Neurol Int. 2018;9:91. 10.4103 eCollection 2018.","journal-title":"Surg Neurol Int"},{"key":"431_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s42238-021-00061-5","volume":"3","author":"J Moltke","year":"2021","unstructured":"Moltke J, Hindocha C. Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems. J Cannabis Res. 2021;3:5. https:\/\/doi.org\/10.1186\/s42238-021-00061-5.","journal-title":"J Cannabis Res"},{"key":"431_CR28","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3389\/fnmol.2018.00487","volume":"11","author":"C Muller","year":"2018","unstructured":"Muller C, Morales P, Reggio PH. Cannabinoid ligands targeting TRP channels. Front Mol Neurosci. 2018;11:487.","journal-title":"Front Mol Neurosci"},{"key":"431_CR29","doi-asserted-by":"crossref","unstructured":"Nguyen C, Moeller KE, McGuire M, Melton BL. Consumer perception, knowledge, and uses of cannabidiol. Ment Health Clin. 2023;13(5):217\u201324.","DOI":"10.9740\/mhc.2023.10.217"},{"issue":"6","key":"431_CR30","first-page":"589","volume":"20","author":"A Osman","year":"1997","unstructured":"Osman A, Barrios FX, Kopper BA, et al. Factor structure, reliability, and validity of the Pain Catastrophizing Scale. Psychol J Behav Med. 1997;20(6):589\u2013605.","journal-title":"Psychol J Behav Med"},{"issue":"3","key":"431_CR31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.21037\/tp.2017.04.08","volume":"6","author":"DR Patel","year":"2017","unstructured":"Patel DR, Yamasaki A, Brown K. Epidemiology of sports-related musculoskeletal injuries in young athletes in the United States. Transl Pediatr. 2017;6(3):160\u20136.","journal-title":"Transl Pediatr"},{"issue":"2","key":"431_CR32","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","volume":"153","author":"RG Pertwee","year":"2008","unstructured":"Pertwee RG. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta 9-tetrahydrocannabinol, cannabidiol and delta 9-tetrahydrocannabivarin. Br J Pharmacol. 2008;153(2):199\u2013215.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"431_CR33","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1089\/can.2017.0012","volume":"2","author":"A Reiman","year":"2017","unstructured":"Reiman A, Welty M, Solomon P. Cannabis as a substitute for opioid-based pain medication: patient self-report. Cannabis Cannabinoid Res. 2017;2(1):160\u20136.","journal-title":"Cannabis Cannabinoid Res"},{"key":"431_CR34","doi-asserted-by":"publisher","first-page":"722550","DOI":"10.3389\/fphys.2021.722550","volume":"12","author":"D Rojas-Valverde","year":"2021","unstructured":"Rojas-Valverde D. Potential Role of Cannabidiol on Sports Recovery: A Narrative Review. Front Physiol. 2021;12:722550. https:\/\/doi.org\/10.3389\/fphys.2021.722550.","journal-title":"Front Physiol"},{"key":"431_CR35","doi-asserted-by":"publisher","first-page":"1210202","DOI":"10.3389\/fphar.2023.1210202","volume":"14","author":"D Rojas-Valverde","year":"2023","unstructured":"Rojas-Valverde D, Fallas-Campos A. Cannabidiol in sports: insights on how CBD could improve performance and recovery. Front Pharmacol. 2023;14:1210202. https:\/\/doi.org\/10.3389\/fphar.2023.1210202.","journal-title":"Front Pharmacol"},{"issue":"4","key":"431_CR36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1249\/FIT.0000000000000589","volume":"24","author":"P Ronai","year":"2020","unstructured":"Ronai P, Gallo PM. The stair climb power test. ACSM health Fit J. 2020;24(4):38\u201342.","journal-title":"ACSM health Fit J"},{"issue":"5","key":"431_CR37","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1248\/bpb.34.774","volume":"34","author":"LR Ruhaak","year":"2011","unstructured":"Ruhaak LR, Felth J, Karlsson PC, et al. Evaluation of the cyclooxygenase inhibiting effects of six major cannabinoids isolated from Cannabis sativa. Biol Pharm Bull. 2011;34(5):774\u20138.","journal-title":"Biol Pharm Bull"},{"issue":"7","key":"431_CR38","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","volume":"152","author":"E Ryberg","year":"2007","unstructured":"Ryberg E, Larsson N, Sj\u00f6gren S, Hjorth S, Hermansson NO, Leonova J, Elebring T, Nilsson K, Drmota T, Greasley PJ. The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol. 2007;152(7):1092\u2013101.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"431_CR39","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neulet.2011.06.004","volume":"500","author":"N Schuelert","year":"2011","unstructured":"Schuelert N, McDougall JJ. The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55. Neurosci Lett. 2011;500(1):72\u20136.","journal-title":"Neurosci Lett"},{"key":"431_CR40","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1519\/JSC.0000000000003269","volume":"34","author":"A Trecroci","year":"2020","unstructured":"Trecroci A, Porcelli S, Perri E, et al. Effects of different training interventions on the recovery of physical and neuromuscular performance after a soccer match. J Strength Cond Res. 2020;34:2189\u201396.","journal-title":"J Strength Cond Res"},{"key":"431_CR41","unstructured":"US HR. 2018. Agriculture Improvement Act of 2018. In: 115th United States Congress. Available at: https:\/\/www.congress.gov\/bill\/115th-congress\/house-bill\/2."},{"issue":"3","key":"431_CR42","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1515\/jbcpp-2015-0080","volume":"27","author":"H Yang","year":"2016","unstructured":"Yang H, Zhou J, Lehmann C. GPR55 \u2013 a putative type 3 cannabinoid receptor in inflammation. J Basic Clin Physiol Pharmacol. 2016;27(3):297\u2013302.","journal-title":"J Basic Clin Physiol Pharmacol"},{"issue":"1","key":"431_CR43","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1186\/s12889-021-11282-x","volume":"21","author":"MA Zenone","year":"2021","unstructured":"Zenone MA, Snyder J, Crooks V. Selling cannabidiol products in Canada: a framing analysis of advertising claims by online retailers. BMC Public Health. 2021;21(1):1285. https:\/\/doi.org\/10.1186\/s12889-021-11282-x.","journal-title":"BMC Public Health"}],"container-title":["Journal of Cannabis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42238-026-00431-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-026-00431-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-026-00431-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:12:52Z","timestamp":1781644372000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42238-026-00431-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["431"],"URL":"https:\/\/doi.org\/10.1186\/s42238-026-00431-x","relation":{},"ISSN":["2522-5782"],"issn-type":[{"value":"2522-5782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional Review Board (IRB201903330) approval and participant written informed consent was obtained prior to study enrollment. All methods were performed according to the Declaration of Helsinki, Good Clinical Practice Guidelines (HE641619), and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors consent to publication and grant the Publisher\u2019s exclusive license for full copyright.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}